+
Ameen
M. Managing chromoblastomycosis. Trop Doct 2010; 40(2):65–7.
+
Ameen
M. Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol 2009; 34(8):849–54.
+
Arenas
R. Chromoblastomycosis. En Jacobs
PH, Nall
L. Antifungal Drug Therapy: A Complete Guide for the Practitioner. New York: Marcel-Dekker 1990:43–50.
+
Badali
H, Bonifaz
A, Barrón-Tapia
T, Vázquez-González
D,
et al. Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Medical Mycology 2010; jan 29 .
+
Barba Gómez
F, Mayorga
J, McGinnis
MR, González Mendoza
A. Chromoblastomycosis caused by Exophiala spinifera. J Am Acad Dermatol 1992; 26:367–70.
+
Bonifaz
A, Carrasco Gerard
E, Saúl
A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001; 44:1–7.
+
Caligiorne
RB, Resende
MA de, Dias-Neto
E,
et al. Dematiaceous fungal pathogens: analysis of ribosomal DNA gene polymorphism by polymerase chain reaction-restriction fragment length polymorphism. Mycoses 1999; 42:609–14.
+
de Sousa Mda
G, Belda
W Jr, Spina
R,
et al. Topical application of imiquimod as a treatment for chromoblastomycosis. Clin Infect Dis 2014; 58(12):1734–7.
+
Dos Santos
A, Minelli
L. Melanoma in a long-standing lesion of chomoblastomycosis. Int J Dermatol 2006; 45:1331–1333.
+
Esterre
P, Queiroz-Telles
F. Management of chromoblastomycosis: Novel perspectives. Curr Opin Infect Dis 2006; 19:148–152.
+
Estrada-Chávez
G, Arenas
R, Vega-Memije
ME, Bonifaz
A.
Cromoblastomicosis: un caso por Fonsecaea pedrosoi con filamentación in vivo y tratamiento combinado con itraconazol y criocirugía. Dermatología DCMQ 2003; 1(1):40–3.
+
Javad-Najafzadeh
M, Sun
J, Vicente
VA, Klaassen
CHW, Bonifaz,
A, Ende
G van, Menken
SBJ, de Hoog
GS. Molecular Epidemiology of Fonsecaea Species. Emerg Infect Dis 2011; 17(3):464–469.
+
Lavalle
P. Chromoblastomycosis in Mexico. Proceed 5th Int Conf Myc Scien. Pub No. 396. Pan Am Health Org 1980: 235–47
+
Lee
MW, Hsu
S, Rosen
T. Spores and mycelia in cutaneous chromomycosis. J Am Acad Dermat 1998; 39(5 Pt 2):850–2.
+
Lim
SW, Suh
MK, Kang
GS, Ha
GY, Kim
H, Choi
JS, Kim
YS. Molecular phylogenetics of Fonsecaea strains isolated from chromoblastomycosis patients in South Korea. Mycoses 2011; 54(5): e415–e420.
+
López-Martínez
R, Méndez-Tovar
LJ. Chromoblastomycosis. Clin Dermatol 2007; 25:188–94.
+
Minotto
R, Varejao-Bernardi
CD, Mallmann
LF,
et al. Chromoblastomycosis: a review of 100 cases of Rio Grande do Sul. Brazil J Am Acad Dermatol 2001; 44:585–92.
+
Najafzadeh
MJ, Sun
J, Vicente
V, Xi
L, van den Ende
AH, de Hoog
GS. Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data. Med Mycol 2010; 48(6):800–6.
+
Paniz-Mondolfi
AE, Colella
MT, Negrín
DC,
et al. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole. Med Mycol 2008; 46(2):179–84.
+
Queiroz-Telles
F, Esterre
P, Pérez-Blanco
M, Vitales
R, Guedes
C, Bonifaz
A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Medical Mycology 2009; 47(1):3–15.
+
Queiroz-Telles
F, de CL Santos
DW. Challenges in the Therapy of Chromoblastomycosis. Mycopathologia 2013; 175(5-6):477–88.
+
Ranawaka
RR, Amarasinghe
N, Hewage
D. Chromoblastomycosis: combined treatment with pulsed itraconazole therapy and liquid nitrogen cryotherapy. Int J Dermatol 2009; 48(4):397–400.
+
Saeb
M, Arenas
R. Cromoblastomicosis: informe de cinco casos con énfasis histopatológico y terapéutico. Derm Venez 1999; 37(2):46–50.
+
Sarti
HM, Vega-Memije
ME, Domínguez-Cherit
J, Arenas
R. Longitudinal melanonychia secondary to chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol 2008; 47:764–765.
+
Scheinfeld
N. A review of the new antifungals: posaconazole, micafungin, and anidulafungin. J Drugs Dermatol 2007; 6(12):1249–51.
+
Torres
E, Gil-Berinstain
J, Lievanos
Z, Arenas
R. Carcinoma epidermoide como complicação letal de lesões crônicas de cromoblastomicose. Ann Brasil Dermatol 2010; 85(10):157–60.
+
Yang
Y, Hu
Y, Zhang
J,
et al. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy. Med Mycol 2012; 50(6):649–653.